Mindray's New TE7 Max Ultrasound System Expands Possibilities for Point of Care
|
By MedImaging International staff writers Posted on 27 Oct 2021 |

Mindray North America (Mahwah, NJ, USA) has launched its new TE7 Max ultrasound system that maximizes the potential of ultrasound in the Point of Care (POC) market.
The TE7 Max has a 21.5 inch vertically oriented high-definition LED display and a sealed touch-based interface to maximize what clinicians can see. Designed to exceed the requirements of demanding POC environments, the system provides best-in-class image quality and a superior user experience during rapid clinical assessments and procedures. Unlike traditional POC ultrasound machines (POCUS), the TE7 Max provides clinicians with comprehensive and customizable workflow protocols (iWorks™) and an extensive suite of artificial intelligence (AI) powered Smart Tools, all in a compact footprint so they can quickly move from patient-to-patient prioritizing efficiency, reproducibility, and quality for all end-users.
Using AI-powered Smart Tools (Smart B-Line, Smart VTI, Smart IVC), the portable ultrasound system can help assess volume status and fluid responsiveness in critically ill patients. With advanced applications (Smart FHR, Smart Bladder, Auto EF), the TE7 Max can help clinicians during rapid clinical assessments and procedures at patients' bedside or on the go. It is also equipped with the most advanced suite of needle-guidance technologies (eSpacial Navi™ 4D Magnetic Needle Navigation Technology and iNeedle+™) to help streamline workflow and improve accuracy with needle-guided procedures.
The slim cart and large screen beautifully display Mindray's leading-edge technologies and everyday applications that meet the diverse, evolving demands of POC environments. Additionally, the TE7 Max ultrasound machine is backed by Mindray's exclusive Living Technology™ promise that provides customers with easily upgradable software enhancements to secure product investment protection and keep their ultrasound machines at the leading edge of imaging performance excellence throughout the product's life cycle.
"Five years ago, Mindray set a new standard for Point of Care ultrasound with the launch of the TE7," said Maher Elhihi, Mindray's Sr. Director of Marketing, Ultrasound. "That system was truly ahead of its time, and today many of our competitors have tried to emulate. As a leader in Emergency Medicine ultrasound, it is our responsibility to push the technology forward, and the new TE7 Max raises the bar yet again and empowers our customers to provide the highest quality of care now and in the future."
Related Links:
Mindray North America
Latest Ultrasound News
- AI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
- Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
- New Ultrasound AI Tool Supports Rapid Prenatal Assessment
- New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
- Groundbreaking Technology to Enhance Precision in Emergency and Critical Care
- Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
- AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
- Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection
- Portable Imaging Scanner to Diagnose Lymphatic Disease in Real Time
- Imaging Technique Generates Simultaneous 3D Color Images of Soft-Tissue Structure and Vasculature
- Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
- Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
- Ultrasound Probe Images Entire Organ in 4D

- Disposable Ultrasound Patch Performs Better Than Existing Devices
- Non-Invasive Ultrasound-Based Tool Accurately Detects Infant Meningitis
- Breakthrough Deep Learning Model Enhances Handheld 3D Medical Imaging
Channels
Radiography
view channel
Simple Chest X-Ray Measure Predicts Survival After Lung Cancer Surgery
Obstructive ventilatory disorder, marked by airflow limitation that reduces breathing efficiency, increases postoperative risk in patients with lung cancer. Although surgery offers the best chance of cure,... Read more
AI Detection Tool Improves Identification of Lobular Breast Cancer
Breast cancer screening seeks early detection, yet some subtypes remain difficult to visualize on mammography, risking delayed diagnosis. On average, 1 in 20 women worldwide will develop breast cancer,... Read moreMRI
view channel
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read more
AI System Improves Accuracy of Cardiac MRI Interpretation
Cardiac magnetic resonance imaging (MRI) is the reference standard for assessing cardiac structure, function, and tissue health. Yet each exam can contain hundreds to thousands of images across multiple... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channelMultimodal AI Tool Combines CT and Health Records to Predict Heart Risk
Cardiovascular disease is a leading cause of death and an underrecognized risk for people treated for breast cancer. Cardiac complications can affect survival and quality of life. Clinicians need tools... Read more
AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more




 Guided Devices.jpg)


